Reevaluating the Use of Guaifenesin in the Management of Acute Cough Associated With the Common Cold
Despite its popularity and its status as an FDA-approved expectorant, evidence to support guaifenesin’s efficacy is limited and conflicting.
Yoseph Raja, PharmD
Advertisement
Articles by Yoseph Raja, PharmD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Drug Topics
1
Embedded Pharmacists Are Vital Yet Underutilized in Diabetes Care
2
The Prodigious PBM Pivot: How Supply Chain Entities Will Move Forward After CAA 2026
3
Executive Order Calls for Realignment of Childhood Vaccines
4
Pneumococcal Vaccination at 50 Years Old Can Improve Outcomes
5